ISU ABXIS Co.,Ltd. (086890) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Document Sample
ISU ABXIS Co.,Ltd. (086890) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Powered By Docstoc
					                 ISU ABXIS Co.,Ltd. (086890) - Pharmaceuticals & Healthcare - Deals and
                                            Alliances Profile
       Reference Code: GDPH196243D                                                                                                           Publication Date: MAR 2013

      Company Overview                                                                                            Key Facts
      ISU ABXIS Co.,Ltd. (ISU ABXIS) is a biotechnology company, based in Republic of
                                                                                                                  ISU ABXIS Co.,Ltd., Pharmaceuticals & Healthcare,
      Korea. The company develops and markets antibody drugs in the areas of cancer,
                                                                                                                  Key Facts, 2011
      autoimmune and inflammatory diseases. It operates through two business segments
      such as Medical and Diagnostic and the Medical division of ISU. ABXIS develops                               Web Address                   www.abxis.com
      therapeutic antibodies such as Clotinab- a Fab fragment of a therapeutic antibody
                                                                                                                   Revenue (US$ million)                            4.62
      for GP IIb/IIIa receptor; ISU101 -a monoclonal therapeutic antibody targeting EGFR;
      ISU302 & ISU303, and ISU201 -a novel antigen. The company’s Diagnostic division                              Number of Employees                               102
      offers genetic testing services, chemotherapy response assay and development and                             GlobalData
      manufacturing of tissue microarray.

      Financial Deals Landscape
        ISU ABXIS Co.,Ltd., Pharmaceuticals & Healthcare, Deals by                         ISU ABXIS Co.,Ltd., Pharmaceuticals & Healthcare, Deals
        Type, 2007 to YTD 2013                                                             By Year, 2007 to YTD 2013


                                                                                                                           2
                                                                                                              2

                                                                                               No. of Deals
                                                                                                                     1
                                                                                                              1


                                                                                                                                  0      0      0      0      0
                                                                                                              0
                                                                                                                   2007   2008   2009   2010   2011   2012   YTD
                                                                                                                                                             2013


                                                                                           Note: Deals include all announced pharmaceuticals & healthcare deals
         Note: Deals include all announced pharmaceuticals & healthcare deals from
                                                                                           from 2006 onwards, GlobalData
         2006 onwards, GlobalData


         ISU ABXIS Co.,Ltd., Pharmaceuticals & Healthcare, Deals
         By Region, 2007 to YTD 2013


                         3
          No. of Deals




                               3         3
                         2

                         1
                                                  0        0         0
                         0
                              Asia-    Europe   Middle   North    South
                             Pacific             East    Americ    and
                                                 and       a      Central
                                                Africa            Americ
                                                                    a



         Note: Deals include all announced pharmaceuticals & healthcare deals
         from 2006 onwards, GlobalData


        ISU ABXIS Co.,Ltd., Pharmaceuticals & Healthcare, Deals Summary, 2007 to YTD 2013
        Year                                                                    No. of Deals                                       Deal Value (US$ million)
        2007                                                                                                         1                                              NA
        2008                                                                                                         2                                               NA
        2009                                                                                                        NA                                               NA
        2010                                                                                                        NA                                               NA
        2011                                                                                                        NA                                               NA
        2012                                                                                                        NA                                               NA
        YTD 2013                                                                                                    NA                                               NA
        Note: Deals include all announced pharmaceuticals & healthcare deals from 2006 onwards, deal values included wherever disclosed, GlobalData



ISU ABXIS Co.,Ltd. - Pharmaceuticals & Healthcare - Deals and                                                                                  Reference Code: GDPH196243D
Alliances Profile
Source : www.globalcompanyintelligence.com                                                                                                                                 Page 1
© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
       Table of Contents
       Table of Contents ............................................................................................................................................................................... 2
          List of Tables .................................................................................................................................................................................. 3
          List of Figures ................................................................................................................................................................................. 3
       ISU ABXIS Co.,Ltd., Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013 .................................................................. 4
       ISU ABXIS Co.,Ltd., Pharmaceuticals & Healthcare Deals By Type, 2007 to YTD 2013 ................................................................... 5
       ISU ABXIS Co.,Ltd., Pharmaceuticals & Healthcare, Deals By Region, 2007 to YTD 2013 ............................................................... 6
       ISU ABXIS Co.,Ltd., Pharmaceuticals & Healthcare, Deals Summary, 2007 to YTD 2013 ................................................................ 7
       ISU ABXIS Co.,Ltd., Pharmaceuticals & Healthcare, Deal Details ..................................................................................................... 8
          Partnerships.................................................................................................................................................................................... 8
             Antitope Enters Into Co-Development Agreement With ISU ABXIS ............................................................................................ 8
          Licensing Agreements .................................................................................................................................................................... 9
             Crucell Enters Into Licensing Agreement With ISU ABXIS.......................................................................................................... 9
             Crucell Enters Into Licensing Agreement With ISU ABXIS For STAR Technology ................................................................... 10
       ISU ABXIS Co.,Ltd. - Key Competitors ............................................................................................................................................. 11
       Key Employees .............................................................................................................................................
				
DOCUMENT INFO
Description: ISU ABXIS Co.,Ltd. (ISU ABXIS) is a biotechnology company, based in Republic of Korea. The company develops and markets antibody drugs in the areas of cancer, autoimmune and inflammatory diseases. It operates through two business segments such as Medical and Diagnostic and the Medical division of ISU. ABXIS develops therapeutic antibodies such as Clotinab- a Fab fragment of a therapeutic antibody for GP IIb/IIIa receptor; ISU101 -a monoclonal therapeutic antibody targeting EGFR; ISU302 & ISU303, and ISU201 -a novel antigen. The company’s Diagnostic division offers genetic testing services, chemotherapy response assay and development and manufacturing of tissue microarray. ISU ABXIS is headquartered in Seoul, Republic of Korea.
BUY THIS DOCUMENT NOW PRICE: $250 100% MONEY BACK GUARANTEED
PARTNER GlobalData
GlobalData is an industry analysis specialist, providing business information products and services. GlobalData’s highly qualified team of analysts, researchers, and solution consultants use proprietary data sources, tools and techniques to gather, analyze and represent the latest and the most reliable information essential for a business to sustain a competitive edge. GlobalData is a UK-based company with presence across North America, Europe and Asia Pacific and has a broad product offering that ranges from interactive databases, reports and custom solutions. It is a comprehensive source of insights and analysis with coverage across the oil & gas, power, alternative energy, nuclear power, petrochemicals, medical equipment and healthcare industries. GlobalData has a broad range of coverage over key market segments. It has a global scope, covering a wide range of countries constituting more than 90% of global revenues in each of the industries it covers. With a large dedicated research and analysis capability, GlobalData employs rigorous primary and secondary research techniques in developing unique data sets and research materials. Its status as an independent research company allows Analysts to conduct trade interviews with key industry players. Access to unique databases of in-house market information further strengthens research and analysis capabilities. Materials are reviewed shaped by an expert panel of leading industry figures and representatives from key players in the relevant industries. Sectors and Geographies Covered GlobalData has a broad range of coverage over key market segments. It has a global scope, covering a wide range of countries constituting more than 90% of global revenues in each of the industries it covers. Research Methodology With a large dedicated research and analysis capability, GlobalData employs rigorous primary and secondary research techniques in developing unique data sets and research materials. Its status as an independent research company allows Analysts to conduct trade interviews with key industry players. Access to unique databases of in-house market information further strengthens research and analysis capabilities. Materials are reviewed shaped by an expert panel of leading industry figures and representatives from key players in the relevant industries.